Financial Times: The world’s largest maker of generic drugs said Chinese imports of amoxicillin trihydrate, an active ingredient of the most widely used antibiotic in Europe, reflected “significant state intervention” and “non-market pricing”, according to a complaint submitted in March and seen by the FT.
The Swiss group, which was spun off from Novartis in 2023, has asked the Commission for “corrective” measures to protect the EU’s industry and the “resilience of its supply of this key medicinal ingredient”…